Explore this case study to see how Quantum-Si’s protein barcoding is helping UMC Utrech to develop novel delivery approaches for creating CAR T cells <em>in vivo</em>, including non-viral delivery combined with DNA- and RNA-transposase technologies.
Explore this case study to see how Sanavia Oncology’s interest in next-gen protein sequencing (NGPS) using the Quantum-Si’s Platinum® instrument stems from their need to better characterize novel cancer targets, and why they see it as a crucial tool in their target identification workflow.
Dive into this case study to see how KWEHealth is exploring cutting-edge technologies to advance exosome-based therapeutics. They view next-gen protein sequencing (NGPS) as a game-changer and are leveraging its capabilities to drive progress in their research. Learn how NGPS is shaping their approach.
Explore this case study to learn how researchers at Gipfel are using Platinum® to enhance their capabilities in a wide range of applications like Identifying novel biomarkers, uncovering deeper insights into non-druggable disease pathways and phenotyping neglected diseases.
Explore this case study to learn how researchers are using the protein barcoding application on Platinum® to accelerate development of novel gene therapies with improved targeting capabilities.
Explore the case study to understand how researchers are using Platinum® as a powerful and complementary technology to mass spectrometry to investigate how proteoform variation underlies human disease.
Explore the case study to understand how combining next-generation protein sequencing with protein barcoding facilitates high-throughput mapping of protein conformations and phenotypic effects, without the limitations of traditional methods.